Food Allergies

Back

Practice Essentials

Food allergies are immunologically mediated adverse reactions to foods. Any food protein can trigger an allergic response, and allergic reactions to a large number of foods have been documented; however, only a small group of foods account for most of these reactions. Eggs, milk, peanuts, soy, fish, shellfish, tree nuts, and wheat are the foods most often implicated.

Signs and symptoms

Signs and symptoms of food-induced anaphylaxis can include the following:

Necessary elements of a thorough medical history include the following:

In addition, obtain a thorough description of each reaction, including the following:

Physical examination findings are most useful for the following:

See Clinical Presentation for more detail.

See All About Allergies: Be Ready for Spring, a Critical Images slideshow, to help identify a variety of allergens and symptoms.

Diagnosis

Laboratory studies that may be helpful include the following:

Skin testing includes the following approaches:

Diet-related diagnostic measures may be helpful, as follows:

See Workup for more detail.

Management

There are currently no curative therapies for food allergy. The only proven treatment is strict dietary elimination of the offending food allergen. A properly managed, well-balanced elimination diet includes the following elements:

Adherence to avoidance measures notwithstanding, accidental or inadvertent ingestions may occur and lead to a reaction. Strategies for dealing with such a reaction include the following:

Emergency medications include the following:

In severe anaphylaxis, ventilatory and circulatory support may be needed.

Oral or sublingual immunotherapy appears to be a promising therapeutic option for the future.[3, 4]

See Treatment and Medication for more detail.

Background

Food allergies are immunologically mediated adverse reactions to foods. Such allergies can result in disorders with an acute onset of symptoms following ingestion of the triggering food allergen (eg, anaphylaxis), as well as in chronic disorders (eg, atopic dermatitis, eosinophilic esophagitis). Symptoms observed in a food-induced anaphylactic reaction may involve the skin, gastrointestinal tract, and respiratory tract. (See Pathophysiology, Etiology, and Presentation.)[5]

Any food protein can trigger an allergic response, and allergic reactions to a large number of foods have been documented; however, only a small group of foods account for most of these reactions. Eggs, milk, peanuts, soy, fish, shellfish, tree nuts, and wheat are the foods most often implicated in allergic reactions that have been confirmed in well-controlled, blinded food challenges (medically supervised, gradual test feedings) . Sesame appears to be an emerging allergen. (See Etiology and Workup.)

Investigations of near-fatal or fatal anaphylactic reactions following food ingestion reveal that most are caused by peanuts, tree nuts, and shellfish, although milk has been increasingly reported. (See Workup.)[6]

Adverse reactions to food that are not immune mediated are not considered to be food allergies. An example is lactose intolerance, which is caused by a deficiency of lactase. Adverse reactions to foods can also occur from toxic (eg, bacterial food poisoning) or pharmacologic (eg, caffeine) effects.

Pathophysiology

Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Symptoms range from acute urticaria (most common) to flushing to angioedema to exacerbations of atopic dermatitis. Food allergy is rarely the cause of chronic urticaria or angioedema.

Atopic dermatitis

Controversy surrounds the role of food allergy in the pathogenesis of atopic dermatitis.[7] Studies show that among patients with moderate chronic atopic dermatitis, 35-40% have IgE-mediated food allergy.[8, 9] Food-specific IgE-mediated and cellular mechanisms appear responsible for chronic eczematous inflammation.

Removal of a specific food allergen may lead to reduction or resolution of clinical symptoms in affected patients; reintroduction of the food may then exacerbate the atopic dermatitis if it is food-responsive.[10, 11] Reintroduction of a suspected food allergen should be performed under medical supervision because, in some instances, initial reintroduction of the food after a period of dietary elimination has resulted in more significant symptoms than were observed when the food was regularly ingested.[12]

In a study of 619 exclusively breastfed infants, those with atopic dermatitis were significantly more likely to be sensitized to foods.[13, 14] In addition, a strong association between the severity of the dermatitis and sensitization was observed, and positive associations between atopic dermatitis and specific foods (egg, cow’s milk, and peanut) were found.

In addition to skin-prick testing against cow's milk, egg, cod fish, wheat, sesame, and peanut, infants in the study were screened for filaggrin loss-of-function (FLG) gene mutations.[14] FLG mutations were significantly associated with incidence of atopic dermatitis and higher median transepidermal water loss relative to dermatitis severity. Although children with atopic dermatitis were significantly more likely to be sensitized to foods, this effect was not related to FLG mutation inheritance.

Celiac disease

Celiac disease is the result of an immune response to gluten proteins in grain.

Dermatitis herpetiformis

This is a form of non-IgE cell-mediated hypersensitivity related to celiac disease. It is a blistering skin disorder that manifests clinically with a chronic and intensely pruritic rash with a symmetrical distribution. Elimination of gluten from the diet usually leads to resolution of skin symptoms.

IgE-mediated gastrointestinal food allergy

These food allergy reactions include immediate hypersensitivity reactions and the pollen-food allergy syndrome (oral allergy syndrome). Specific gastrointestinal symptoms include nausea, vomiting, abdominal pain, and cramping. Diarrhea is found less frequently.

Pollen-food allergy syndrome (oral allergy syndrome)

Patients with this syndrome develop itching or tingling of the lips, tongue, palate, and throat following the ingestion of certain foods. In addition, edema of the lips, tongue, and uvula and a sensation of tightness in the throat may be observed. In fewer than 3% of cases, symptoms progress to more systemic reactions, such as laryngeal edema or hypotension.[15]

This syndrome is caused by cross-reactivity between certain pollen and food allergens. For example, individuals with ragweed allergy may experience oropharyngeal symptoms following the ingestion of bananas or melons, and patients with birch pollen allergy may experience these symptoms following the ingestion of raw carrots, celery, potato, apple, peach or hazelnut.

Mixed IgE/non-IgE gastrointestinal food allergy (eosinophilic esophagitis and gastroenteritis)

Symptoms vary according to location of the eosinophilia. Typical symptoms include postprandial nausea, abdominal pain, and a sensation of early satiety. Eosinophilic esophagitis may manifest as reflux symptoms and dysphagia; food impaction can occur as well. Children may experience weight loss or failure to thrive.[16]

A complete blood count (CBC) and differential findings may show eosinophilia in approximately 50% of patients; however, this is not diagnostic. Typically, endoscopy and biopsy must be performed in order to establish the presence of eosinophils in the affected segment of the gut. While a dense eosinophil infiltrate may be seen anywhere from the lower esophagus through the large bowel, involvement is patchy and variable.

Eosinophilic esophagitis is characterized by symptoms related to esophageal dysfunction, such as dysphagia and pain, and histologically by eosinophil-predominant inflammation. Pathologically, 1 or more biopsy specimens must show a peak of 15 or more eosinophils per high power field. Alternative explanations (eg, reflux) for symptoms/histopathologic abnormalities should be excluded.

An elemental (no potential allergens) or oligoantigenic diet (a diet that removes common allergenic foods) and trials of food elimination may be required to determine the role of foods in a patient's condition.

In addition to diet therapy (or in place of diet therapy), treatment with anti-inflammatory medications (eg, corticosteroids) may be needed. Eosinophilic esophagitis appears to be a chronic disease and fibrosis and stricture formation could occur. Updated diagnostic and treatment approaches have been proposed.[17]

Non–IgE-mediated gastrointestinal food allergy

Food protein–induced enterocolitis syndrome (FPIES) typically manifests in the first few months of life with severe projectile vomiting, diarrhea, and failure to thrive.[18] Cow milk and soy protein formulas are usually responsible for these reactions. However, solid foods may also trigger these reactions, especially rice and oats.[19]

When the allergen is removed from the diet, symptoms resolve. Reexposure prior to resolution results in a delayed (2h) onset of vomiting, lethargy, increase in the peripheral blood polymorphonuclear leukocyte count, and, later, diarrhea. Hypotension and methemoglobinemia may occur.

Infants with FPIES who are chronically ingesting the allergen typically appear lethargic, wasted, and dehydrated. The presentation may mimic sepsis. An oral food challenge may establish the diagnosis but is not always needed if the history is clear. No other definitive diagnostic tests are available.

Breastfed infants may have mucus and blood in their stool, attributed to food allergens ingested by the mother, primarily cow milk. This allergic proctocolitis does not typically lead to anemia and is not associated with vomiting or poor growth. Maternal exclusion of the allergen resolves the bleeding. Eosinophilic inflammation of the rectum is noted if a biopsy is performed.[20] Additional causes of bleeding (eg, infection, fissures) should be considered.

Upper and lower respiratory tract reactions

Upper respiratory reactions typically include nasal congestion, sneezing, nasal pruritus, or rhinorrhea. They are usually observed in conjunction with ocular, skin, or gastrointestinal symptoms. IgE-mediated pulmonary symptoms may include laryngeal edema, cough, or bronchospasm.

Asthma

Although wheezing can occur during a food-allergic reaction, foods do not appear to be a common trigger for chronic asthma.[21, 22, 23]

Food-induced pulmonary hemosiderosis (Heiner syndrome)

This is a rare disorder characterized by recurrent episodes of pneumonia associated with pulmonary infiltrates, hemosiderosis, gastrointestinal blood loss, iron deficiency anemia, and failure to thrive in infants.

While the precise immunologic mechanism is unknown, it is thought to be secondary to a non-IgE hypersensitivity process.

Etiology

Food allergies are primarily the result of immune responses to food proteins. (Allergic reactions to non-protein food additives are uncommon.[22] ) Normally, noninflammatory immune responses develop to ingested foods in a process called oral tolerance.[24, 25] For reasons that remain unclear, but likely include environmental and genetic factors, tolerance may be abrogated, leading to adverse immune responses.

While sensitization (eg, development of an immunoglobulin E [IgE] immune response) to an allergen has been primarily assumed to occur from ingestion, this may not always be the case. For example, oral allergy syndrome (pollen-food related syndrome) describes an allergic response to specific raw fruits or vegetables that share homologous proteins with pollens; the initial route of sensitization is respiratory exposure to pollen proteins rather than oral exposure to food proteins. The skin may be another potential route of sensitization.[26]

IgE antibody-mediated responses

IgE antibody–mediated responses are the most widely recognized form of food allergy and account for acute reactions. Patients with atopy produce IgE antibodies to specific epitopes (areas of the protein) of one or more food allergens. These antibodies bind to high-affinity IgE receptors on circulating basophils and tissue mast cells present throughout the body, including in the skin, gastrointestinal tract, and respiratory tract.

Subsequent allergen exposure binds and cross links IgE antibodies on the cell surface, resulting in receptor activation and intracellular signaling that initiates the release of inflammatory mediators (eg, histamine) and synthesis of additional factors (eg, chemotactic factors, cytokines) that promote allergic inflammation. The effects of these mediators on surrounding tissues result in vasodilatation, smooth muscle contraction, and mucus secretion, which, in turn, are responsible for the spectrum of clinical symptoms observed during acute allergic reactions to food.

Cell-mediated responses

Cell-mediated responses to food allergens may also mediate allergic responses, particularly in disorders with delayed or chronic symptoms. For example, food protein–induced enterocolitis syndrome (FPIES), a gastrointestinal food allergy, appears to be mediated by T-cell elaboration of the cytokine tumor necrosis factor (TNF)-alpha.[27] Persons with atopic dermatitis that flares with ingestion of milk have been noted to have T cells that, in vitro, express the homing receptor cutaneous lymphocyte antigen, which is thought to home the cell to the skin and mediate the response.[28] Celiac disease is the result of an immune response to gluten proteins in grains.

Characteristics of food allergens

Food allergens are typically water-soluble glycoproteins resistant to heating and proteolysis with molecular weights of 10-70 kd. These characteristics facilitate the absorption of these allergens across mucosal surfaces. Numerous food allergens are purified and well-characterized, such as peanut Ara h1, Ara h2, and Ara h3; chicken egg white Gal d1, Gal d2, and Gal d3; soybean-Gly m1; fish-Gad c1; and shrimp-Pen a1.

Closely related foods frequently contain allergens that cross-react immunologically (ie, lead to the generation of specific IgE antibodies detectable by skin prick or in vitro testing) but less frequently cross-react clinically.[2] Delayed allergic reactions to meat proteins have been attributed to reactions to carbohydrate moieties.[29]

Risk factors

Risk factors or associations for fatal food-induced anaphylaxis include: (1) the presence of asthma, especially in patients with poorly controlled disease; (2) previous episodes of anaphylaxis with the incriminated food; (3) a failure to recognize early symptoms of anaphylaxis; and (4) a delay or lack of immediate use of epinephrine to treat the allergic reaction.[30, 6] Teenagers and young adults appear to be overrepresented in registries of food allergy fatalities and present a special risk group.

Epidemiology

General surveys report that as many as 25–30% of households consider at least 1 family member to have a food allergy.[31, 32] However, this high rate is not supported by controlled studies in which oral food challenges are used to confirm patient histories.

Comprehensive studies that include oral food challenges are few in number. Considering allergy to milk, egg, peanut, and seafood in a meta-analysis of 6 international studies using oral food challenges, estimated rates of 1–10.8% were obtained.[33]

In a meta-analysis including allergy to fruits and vegetables (excluding peanut), only 6 international studies included oral food challenges, and estimates of allergy varied widely from 0.1–4.3% for fruits and tree nuts to 0.1–1.4% for vegetables to under 1% for wheat, soy, and sesame.[34]

Sex- and age-related demographics

Among children, males appear to be more affected; among adults, females are more frequently affected.[35] The prevalence of food allergies has been estimated to be up to 8% in infants and children and 3.7 % in adults.[36]

However, variations in prevalence have been reported according to method used (self report, testing, physician evaluation), geographic region, and foods included in the assessment.[37]

In a population-based survey study of 40,443 US adults, an estimated 10.8% were food allergic at the time of the survey, whereas nearly 19% of adults believed that they were food allergic. Nearly half of food-allergic adults had at least 1 adult-onset food allergy, and 38% reported at least 1 food allergy–related ED visit in their lifetime.[38]

Studies in the United States and the United Kingdom indicate a rise in peanut allergy among young children in the past decade.[35, 39] One study showed an increase of peanut allergy in children from 0.4% in 1997 to 0.8% in 2002.[35] Studies from Canada and the United Kingdom indicate allergy rates to peanut of over 1% in children.[40, 41]

A report from the US Centers for Disease Control and Prevention (CDC) indicated that among children aged 0–17 years, the prevalence of food allergies increased from 3.4% in 1997–1999 to 5.1% in 2009–2011, a 50% rise.[42]

Based on available studies, estimations of the rate of food allergies in children have been summarized as follows for common food allergens:[36]

Prognosis

In general, most infants and young children outgrow or become clinically tolerant of their food hypersensitivities. Specifically, most "outgrow" allergies to milk, egg, soy and wheat. Allergies to peanut, tree nuts, fish, and shellfish are more persistent.[43]

Population-based studies generally show that 85% of young children outgrow their allergy to milk or egg by age 3-5 years.[43] However, studies reported from a referral center showed more persistence of egg, milk, and soy allergies, with only about 50% of patients resolving these allergies by age 8-12 years.[44, 45, 46] Children continued to lose their allergy into adolescent years.

About 20% of infants and young children experience resolution of their peanut allergy by the time they reach school age.

Children with non-IgE–mediated food allergies, such as proctocolitis and enterocolitis, typically resolve their food allergy in the first years of life.[47] Allergic eosinophilic esophagitis appears to be a persistent disorder.[48]

Morbidity and mortality

Severe anaphylactic reactions, including death, can occur following the ingestion of food.[30, 6] Fatalities result from severe laryngeal edema, irreversible bronchospasm, refractory hypotension, or a combination thereof.

Peanuts, tree nuts, fish, and shellfish are the foods most often implicated in severe food-induced anaphylactic reactions, although anaphylactic reactions to a wide variety of foods have been reported. Fatalities caused by reactions to milk have increasingly been noted.[6]

Patient Education

Preparation

Patients should always carry a self-injectable device with epinephrine that has been properly stored and is current (ie, not expired). Ensure that the patient receives proper training regarding when and how to use the injection device. Patients should also have an H1-blocker medication (again, properly stored and not expired) in a syrup or chewable tablet form available. In addition, patients should be instructed to obtain immediate medical assistance (eg, call 911) in the event of anaphylaxis.

Caregivers of children should be instructed on identification and treatment of allergic and anaphylactic reactions.

Avoidance of allergens

Complete avoidance of the offending food allergen is the best strategic approach and the only proven therapy once the diagnosis of food hypersensitivity is established. Therefore, patients with food allergies should be taught to recognize relevant food allergens that must be eliminated from their diet.

Instruct the patient about the proper reading of food labels and the need to inquire about food ingredients when dining out. If the patient is in doubt about a food or food ingredient, suggest avoidance of the food in question. Educate patients about the potential for food allergens to be present in medications and cosmetics.

Support groups

Inform patients with food allergies how to identify and use support groups. One such organization is the Food Allergy Research and Education group.

Early detection and treatment

Educate patients regarding recognition of the early signs and symptoms of a food-induced allergic reaction, and provide them with a written management plan for successfully dealing with these reactions.

Write a specific list of clinical signs and symptoms to look for if a reaction may be occurring, and include a clear management plan. An excellent example of such a plan is available on the Food Allergy Research and Education Web site.

Demonstrate to the patient and family how to actually administer medications, especially injectable epinephrine, in the event of an allergic reaction. To accomplish this, use demonstration trainer devices in the clinic setting. Reinforce that if injectable epinephrine is administered, the patient must be immediately evaluated in a medical setting.

For patient education information, see the Allergies Center, as well as Food Allergy and Severe Allergic Reaction (Anaphylactic Shock).

History and Physical Examination

Symptoms of food-induced anaphylaxis can include the following:

History

Necessary elements of a thorough medical history include the following:

In addition, obtain a thorough description of each reaction, including the following:

Food-associated exercise-induced anaphylaxis describes a disorder in which exercise is tolerated and a food or foods are tolerated, but when exercise follows ingestion of a specific food or foods, anaphylaxis results.[49]

Physical examination

The physical examination findings are most useful for assessing overall nutritional status, growth parameters, and signs of other allergic disease, such as atopic dermatitis, allergic rhinitis, or asthma.

Findings from a comprehensive physical examination can help rule out other conditions that may mimic food allergy.

Approach Considerations

The approach to the diagnosis of food allergy requires consideration of the history, the epidemiology of food allergic disease, cross-reactivity, and the degree of positivity of tests; these must be evaluated to assist in diagnosis. Simple tests for food-specific IgE antibodies are available, but the clinician must appreciate that a positive test for food-specific IgE primarily denotes sensitization and may not confirm clinical allergy. A physician-supervised oral food challenge may be required for diagnosis.

When the history of an allergic reaction to a food suggests that the onset of symptoms is delayed by hours or days following ingestion, adjust the timing and monitoring of the challenge to correspond to these characteristics.

Because specific laboratory tests for some food hypersensitivities are not available, diagnosing non–IgE-mediated food allergies (eg, cow milk–induced and soy-induced enterocolitis syndromes or allergic eosinophilic gastroenteritis) is more difficult than diagnosing IgE-mediated food allergies.

In cases of allergic eosinophilic gastroenteritis, a biopsy may need to be performed. Elimination diets with gradual reintroduction of foods and supervised oral food challenges are often needed to help identify the causative foods.

For food protein–induced enterocolitis syndrome, the oral food challenge is typically performed with 0.15-0.30 g of protein per kilogram of body weight of the implicated protein and observe the patient for several hours. Positive reactions (eg, profuse vomiting, diarrhea) are typically accompanied by a rise in the absolute neutrophil count of more than 3500 cells/mm3 (see the Absolute Neutrophil Count calculator). Because of the potential for shock, these challenges are best performed in the hospital setting.

The successful administration of oral food challenges to young children requires a great deal of preparation, patience, and creativity. Young children may refuse to ingest the challenged food. Prior planning with the family is important to choose proper vehicles (eg, juice, cereal, solid food) for disguising the challenged substance.[50]

Serum Studies

IgE antibody testing

Specific IgE antibodies to foods can be quantified by in vitro laboratory methods. The term RAST (radioallergosorbent test) is antiquated because modern methods do not use radiation.

The serum test may offer advantages over skin prick testing when skin testing is limited by dermatographism, generalized dermatitis, or a clinical history of severe anaphylactic reactions to a given food. However, although the serum test provides information similar to the skin prick test, it is more expensive and results are not immediate.

Studies have correlated the outcomes of physician-supervised oral food challenges with serum test results. While the studies have generally shown increasing risks of reaction with increasing concentrations of allergen, the specific correlations vary among studies.[51, 52] The concentration of food-specific IgE does not correlate very well with the severity of an allergy.

Studies (so far primarily using 1 brand of test system) have reported levels highly indicative of allergy (>95%).[51, 53] However, specific results have varied among studies, which is probably due to differences in patient selection, interpretation of positive outcomes, and other factors. Only a few foods have been analyzed in this manner (primarily peanuts, eggs, and milk), and predictive results are different for the different foods.

Test systems vary with regard to measurements, and similarly reported results may not be equivalent.[54] The clinician should also be aware of different reporting units that are not interchangeable with one another (eg, class vs units vs percentage).

An emerging serum test is component resolved diagnosis (CRD). Foods are composed of many proteins to which an IgE immune response may develop. IgE responses against labile proteins may carry little risk of significant allergy because these proteins presumably do not easily enter the circulation. In contrast, stable proteins are clinically relevant. With peanut, for example, the proteins Ara h 1, Ara h2, Ara h 3, and Ara h 9 are relatively stable, while Ara h 8 is a pollen related protein that is labile. In CRD, positive testing to Ara h 8 with negative results to Ara H 1-3 and 9 is typically not associated with any significant clinical allergy. These types of tests are being evaluated for improved diagnosis for many foods.[55, 56]

Peripheral serum measurements of eosinophils or total IgE concentrations

Abnormal results from these tests do not identify or confirm the diagnosis of food allergy. Likewise, normal values do not exclude diagnosis.

Basophil histamine-release assays

These tests are limited primarily to research settings and have not been shown conclusively to provide reproducible results useful for diagnostic testing in a clinical setting.

Other

Studies are underway to determine, for example, if analysis of IgE epitope binding provides additional diagnostic information.[57]

Diet Diary

This consists of keeping a chronological record of all foods eaten and any associated adverse symptoms. It is an inexpensive endeavor that documents the frequency of symptoms and their occurrence in relationship to food ingestion. In addition, it encourages the patient to focus on his or her diet.

This record is occasionally helpful for identifying the food implicated in an adverse reaction; however, it is not usually diagnostic, especially when symptoms are delayed or infrequent.

Occasionally, review of the diet diary reveals that the patient is not experiencing a reaction when eating, as an ingredient in other foods, a significant amount of a food to which he or she was thought to be allergic.

Elimination Diet

This is used for diagnostic and treatment purposes. When used as a diagnostic tool, the elimination diet requires complete avoidance of suspected foods or groups of foods for a given time period (usually 7-14d) while the patient is monitored for an associated decrease in symptoms. The trial elimination diet may be most useful to evaluate chronic symptoms.

Success depends on identifying the correct food allergen and completely eliminating it from the diet. Limitations of this method include potential effects of patient or physician biases, variable patient compliance, and the time-consuming nature of the endeavor.

If symptoms improve, confirmation of the food as causal typically requires a medically supervised oral food challenge.

When the elimination diet is used as treatment, identified food allergens are removed from the diet indefinitely unless evidence exists that the food allergy has resolved.

Skin Testing

Prick and puncture tests are the most common screening tests for food allergy and can even be performed on infants in the first few months of life. However, the reliability of the results depends on multiple factors, including use of the appropriate extracts and testing technique, accurate interpretation of the results, and avoidance of medications that might interfere with testing (eg, antihistamines).[58, 59]

When used in conjunction with a standard criterion of interpretation and appropriate controls (eg, histamine: positive; saline: negative), these tests provide useful and reproducible clinical information in a short period (ie, 15-20 min), with minimal expense and negligible risk to the patient.

This is a reliable method of excluding IgE-mediated food allergies. The negative predictive accuracy is generally greater than 90%; however, the positive predictive accuracy is generally less than 50%, which limits clinical interpretation of positive skin test results. Similar to in vitro testing, interpretation of the test results must consider the clinical history (to assess prior probability) and other factors, such as the likelihood, from epidemiologic observations, of the food being an allergy trigger.

The larger the skin test wheal size, the more likely that a clinical allergy exists.[60, 61] Positive skin test results, in addition to the suggestion of clinical reactivity based on the patient’s history, must often be confirmed by an oral food challenge unless the patient has a convincing history of significant food allergy.

Food Challenge Confirmation of Food Allergy

A physician-supervised (medically supervised) oral food challenge involves gradually feeding the patient the food suspected to be causing an allergy, with careful assessment for any symptoms. If symptoms occur, the feeding is discontinued and medications are administered.[62]

Food challenges are typically preceded by a period of elimination of the suspected food. They are conducted when the patient is at a stable clinical baseline and not taking medications that could interfere with the observation of symptoms (eg, antihistamines).

Of these procedures, the double-blind, placebo-controlled food challenge (DBPCFC) is the most reliable method to help diagnose and confirm food allergy and other adverse food reactions, because it eliminates patient and observer bias. However, in a clinical setting where minimal bias is suspected, open food challenges may be preferable, because blinding of the food is often not required.

Conduct any food challenge in a clinic or hospital setting with the personnel and equipment necessary to treat a systemic allergic reaction available at all times. Patients undergoing a food challenge should not be taking beta-blocker medications or any medication that might interfere with the treatment of anaphylaxis. If indicated by risk assessment, obtaining intravenous access may be prudent.

Clinically indicated oral food challenges are not generally performed when the history and test results already support a current diagnosis of allergy to the target food.

The decision to proceed to an oral food challenge must consider many factors, including the likelihood of a reaction, the severity of a reaction if one were to occur, the need to obtain a definitive diagnosis, and social and nutritional factors, among others.

When performing oral food challenges, be prepared to recognize and treat adverse clinical symptoms immediately. Appropriately trained personnel and the necessary equipment for the treatment of anaphylactic shock must be available prior to and throughout the entire oral food challenge and observation period because of the risk of triggering an allergic reaction. Patients should never be instructed to perform a food challenge at home.

Confirm negative results from a double-blind, placebo-controlled food challenge (DBPCFC) using an open feeding (open food challenge) of the food in question in its usual form and quantity before giving final advice on dietary restrictions.

Open food challenge

This test involves the patient ingesting the suspected food, prepared in its customary fashion (ie, the challenge food is not disguised in any way). The patient and the observer (eg, physician, nurse) are aware of the food being ingested. The open food challenge is best used in clinical practice when the patient and physician bias is minimal.

Whenever the results are equivocal, perform a blinded challenge. Patients with a history of a previous reaction should never perform an open food challenge at home, even if the chance that they will develop severe symptoms is remote.

Single-blind food challenge

This challenge involves the patient ingesting the suspected food disguised in a challenge food so that the patient is unaware of the contents.

This type of challenge, which is suitable for clinical practice and some research investigations, is designed to reduce patient bias during the procedure. However, subjective attitudes regarding the outcome of the challenge cannot be completely eliminated.

Double-blind, placebo-controlled food challenge

DBPCFC involves supervised, gradual ingestion of the suspected food disguised in another food (or hidden in capsules). A food similar in taste and appearance, but without the allergen, is used as a placebo control. The feeding (potential allergen vs placebo) is randomized so that the patient and the observer are unaware of the contents of the challenge at the time of the feeding and observation. Feeding of the allergen and placebo may be separated by hours or days.[63]

This type of challenge is designed to reduce patient and observer bias and subjective attitudes during the procedure. DBPCFC is considered the criterion standard for diagnosing food allergies and is particularly used in research investigations. Currently, it is the only completely objective method for determining the validity of the history of an adverse reaction to a food.

Allergy Testing

Intradermal skin testing

The risk of inducing a systemic reaction with this type of testing is increased in comparison with the prick or puncture method; as a result, intradermal skin testing for food allergies should be avoided. In addition, the results obtained by using this method are less specific than are those obtained by using prick or puncture testing.

Patch tests

Patch tests are performed by exposing the skin to the food allergen for 24 hours under occlusion and then evaluating the area for erythema and papules in the subsequent 24-72 hours.

The test has been evaluated for diagnosis of food allergy in eosinophilic esophagitis,[64] enterocolitis,[65] and atopic dermatitis.[66] Some studies show promise for this technique, but additional studies are needed to better characterize the utility of the results.[67]

Peripheral serum measurements of eosinophils or total IgE concentrations

Results from these tests support but do not confirm the diagnosis of food allergy. Likewise, normal values do not exclude diagnosis.

Basophil histamine-release assays

These tests are limited primarily to research settings and have not been shown conclusively to provide reproducible results useful for diagnostic testing in a clinical setting.

Other

The diagnostic value of performing the following tests is not currently supported by objective scientific evidence:

 

Approach Considerations

The only proven medication therapy against a food allergy is strict elimination of the offending food allergen from the diet and avoidance of any contact with the food by ingestion, skin contact, inhalation, or injection.

In 2010, Guidelines for the Diagnosis and Management of Food Allergy in the United States were published. These provide evidenced-based, expert panel recommendations for the diagnosis and management of food allergies.[67] The guidelines do not cover issues for schools, which are of interest to pediatricians, but a 2010 Clinical Report reviews this topic area.[68]

Injectable epinephrine is the drug of choice for the initial management of a food-induced anaphylactic reaction. Ensure that the patient has self-injectable epinephrine readily available at all times. Advanced medical therapy of food allergen–induced anaphylaxis may include antihistamines, bronchodilators, histamine 2 (H2) blockers, corticosteroids, and administration of intravenous fluids, glucagon, and oxygen. In severe anaphylaxis, ventilatory and circulatory support may be needed.

Diet

A properly managed, well-balanced elimination diet (eg, allergen restriction) can lead to resolution of symptoms and help to avoid nutritional deficiencies.

Educate the patient and family about how to properly read food labels and identify common words used for indicating the presence of the food allergen of concern. US labeling laws now require major allergens (ie, egg, milk, wheat, soy, peanut, tree nuts, fish, crustacean shellfish) to be identified as ingredients on manufactured food products using plain English terms. Note that not all potential allergens are included and that some may be subsumed under terms such as spices or natural flavor. Advisory labels (eg, may contain) are not regulated, are voluntary, and may reflect variable risks.

Meal preparation must consider avoidance of cross contact (eg, through shared utensils or fryers) of allergens with otherwise safe foods.

With elimination diets, exclude only those foods confirmed to provoke allergic reactions. Review obvious and hidden sources of food allergens. Be aware of the potential for exposures by routes other than ingestion, such as skin contact, or inhalation. This concern is particularly problematic for foods while they are being cooked, because proteins are dispersed in the steam (eg, frying fish, boiling milk). Educate patients about the potential for food allergens to be present in medications and cosmetics.

Anticipate potential candidates for food allergen cross-reactivity, such as the following:[2]

Encourage avoidance of high-risk situations (eg, buffets, picnics) where accidental or inadvertent ingestion of food allergens can occur. Instruct patients to discuss their food allergies with restaurant and food establishment personnel.

Emergency Plan

Despite following stringent avoidance measures for clinically relevant food allergens, accidental or inadvertent ingestions may occur. Therefore, patients must be instructed on actions to take in the event of a reaction. A concise written plan for the treatment of allergic reactions resulting from accidental exposure to a patient’s food allergen should be developed. Have copies of this plan available in appropriate places (eg, daycare, schools, work locations, college dormitory advisors). Examples of such a plan can be downloaded from www.foodallergy.org

Patients with food allergies should be advised to obtain and wear medical identification jewelry indicating their food allergies.

Ensure that the patient has an emergency contact number available (eg, 911, their physician's office phone number, or a local emergency department) that can be used in the event of a major food-induced allergic reaction.

Anticipatory guidance measures cannot be overemphasized; for example, educate the patient about potential sources of accidental exposure to relevant food allergens (eg, daycare, school, travel, picnics, dining out).

Emergency Medications

Injectable epinephrine is the drug of choice for the initial management of a food-induced anaphylactic reaction. Ensure that the patient has self-injectable epinephrine readily available at all times. Also ensure that the patient receives proper training regarding when and how to use the injection device. An antihistamine should also be available. Patients with food allergies and asthma should always have access to a rapid-acting bronchodilator.

Self-injectable epinephrine is typically available by prescription (ie, EpiPen, EpiPen Jr, Adrenaclick 0.15 mg, Adrenaclick 0.3 mg, Auvi-Q 0.15 mg, Auvi-Q 0.3 mg). These devices should be stored properly (avoiding extremes of temperature) and replaced before the expiration date.

Future Therapeutics

There are currently no curative therapies for food allergy. Injection immunotherapy is an accepted treatment for anaphylactic allergy to insect venoms and for environmental allergies, but it poses a high risk for food allergies (anaphylaxis to injected native food proteins).[69, 70]

Studies are under way to determine if oral, sublingual, or epicutaneous immunotherapy is safe and effective for food allergies, with some promising results.[4] Additional studies are needed to define the safety profile and side effects (short term and long term) and to determine whether treatment affects resolution of the allergy (tolerance without repeated dosing of the allergen) or desensitization (an increased threshold while undergoing dosing). A strategy using anti-IgE antibodies (omalizumab) in conjunction with oral immunotherapy is also under investigations as it may allow faster up-dosing with fewer side effects.

Studies are under way to determine whether therapies with modified food proteins are safe and effective. Promising results from a phase II study support Viaskin Milk as the first potential treatment for IgE-mediated cow's milk protein allergy (CMPA). The study, which evaluated the efficacy and safety of three dose regimens of Viaskin Milk (150 µg, 300 µg, 500 µg) in 198 milk-allergic patients, found a statistically significant desensitization to milk in children ages 2 to 11 years treated with Viaskin Milk 300 µg for 12 months.[71]  

Additional therapeutics may in the future be derived from investigations of cytokine and anticytokine therapies, as well as from the evaluation of traditional Chinese medicine.

Consultations

Consultation with a board-certified allergist/immunologist should be considered when food allergy is suspected or confirmed.

Consultation with a nutritionist or nutrition service is invaluable in the overall management of food allergies. The elimination diet can be reviewed and appropriate substitutions can be recommended. Dietary deficiencies can be anticipated and prevented.

Consultation with a gastroenterologist is also useful in the evaluation of selected patients. For example, patients who present with possible anatomic gastrointestinal abnormalities, eosinophilic esophagitis or gastroenteritis, failure to thrive, and malabsorption syndromes may benefit from consultation with an allergist and a gastroenterologist.

Prevention

Early introduction

The Learning Early about Peanut Allergy (LEAP) study addressed the possibility that early ingestion of peanut, rather than delay, may prevent peanut allergy.[72]

The UK study randomized 640 infants aged 4-11 months at high risk for developing peanut allergy, as defined by having severe eczema, egg allergy or both, to ingest or to avoid peanut to age 5 years. Infants were skin tested with peanut at screening and excluded if they had large test results (>4 mm) on the assumption they were already allergic. Two cohorts were identified: those with negative peanut skin tests (not sensitized) and those with skin test wheals 1-4 mm (sensitized). Infants were randomized 1:1 for avoidance or early consumption (6 g peanut protein/week); 542 were not sensitized to peanut at enrollment. Among the non-sensitized cohort, 13.7% in the avoidance group and 1.9% in the consumption group had peanut allergy at age 5 years (p< 0.001), an 86% reduction. In the sensitized group, the corresponding rates were 35.3% and 10.6%, respectively (p=0.004), a 70% reduction. Overall, those randomized to early ingestion experienced a relative risk reduction of 80%.

A follow-up study had the peanut-tolerant children avoid peanut for a year and undergo re-testing with results suggesting that the children had maintained the benefit even when not eating peanut so frequently.[73]

A Consensus report suggests that infants at high risk, like those in the LEAP study, be evaluated (by testing and possibly a medically supervised feeding) to determine if they can have peanut introduced into the diet early, as early as 4-6 months, to potentially prevent peanut allergy. The report substantially suggests following the LEAP study approach to testing and feeding, which includes using infant-safe forms of peanut protein.[74]

Another study randomized infants, who were not selected for high risk, to early feeding of a variety of allergens from 3 months of age. This study did not show a prevention effect in the intention-to-treat analysis.[75]

 

Medication Summary

For patients with mild reactions, such as localized urticaria, oral itch, or mild abdominal pain, treatment may be limited to an oral antihistamine.

If the patient has systemic symptoms, the treatment of choice is self-injectable epinephrine administered by intramuscular injection in the lateral thigh.[76] Patients must be educated regarding when to use their self-injector and the proper technique. They should also be instructed to obtain immediate medical assistance (eg, call 911) in the event of anaphylaxis.

Epinephrine should likely be administered to any patient with a history of a severe allergic reaction as soon as ingestion of the food allergen is discovered and the first symptoms appear (and possibly even before symptoms appear).

Patients should not depend on bronchodilators or antihistamines to treat anaphylaxis. However, antihistamines can be used as additional therapy during an allergic reaction, and a bronchodilator may be used as adjunctive therapy for asthma.[76] Although corticosteroids are often given for anaphylaxis, they are not believed to alter the early symptoms; theoretically, they may reduce late symptoms.

Diphenhydramine (Anti-Hist, Aler-Dryl, Benadryl)

Clinical Context:  This is a first-generation antihistamine with anticholinergic effects that binds to H1 receptors in the CNS and the body. It competitively blocks histamine from binding to H1 receptors. It is used for symptomatic relief of symptoms caused by release of histamine in allergic reactions.

Cetirizine (Zyrtec)

Clinical Context:  Second-generation histamine H1-receptor antagonist. Competes with histamine on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Available in a variety of oral formulations (tablet, liquid, chewable, oral disintegrating) to allow ease of administration.

Class Summary

These agents act by competitive inhibition of histamine at the H1 receptor. This mediates the wheal and flare reactions, bronchial constriction, mucous secretion, smooth muscle contraction, edema, hypotension, CNS depression, and cardiac arrhythmias.

Epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q)

Clinical Context:  Epinephrine is the drug of choice for the treatment of anaphylaxis. It helps to decrease symptoms of anaphylaxis by increasing systemic vascular resistance, elevating diastolic pressure, producing bronchodilation, and increasing inotropic and chronotropic cardiac activity. In addition, epinephrine helps to reduce urticaria, angioedema, laryngeal edema, and other systemic manifestations of anaphylaxis. Products are available as autoinjectors to ease caregiver or self-administration. Auvi-Q also provides audible instructions and visual cues.

Class Summary

These are used in the emergency management of systemic allergic reactions or anaphylaxis (eg, urticaria, angioedema, bronchospasm, cardiovascular collapse). The effects are immediate and dramatic. The appropriate use of this class of medication can be lifesaving, especially in the emergency management of anaphylaxis.

What are food allergies?What are the signs and symptoms of food allergy-induced anaphylaxis?What should be included in the medical history for food allergies?What is the role of the physical exam findings in the evaluation of food allergies?Which lab tests may be helpful in the diagnosis of food allergies?How is skin testing performed in the diagnosis of food allergies?Which diet-related measures are used in the workup of food allergies?How are food allergies treated?What are the medications used in the emergency treatment of food allergies?What are food allergies?What is the pathophysiology of non–IgE-mediated GI food allergies?What are the clinical manifestations of food allergies?What is the role of food allergies in the pathogenesis of atopic dermatitis?What is the role of food allergies in the pathogenesis of celiac disease?What is the role of food allergies in the pathogenesis of dermatitis herpetiformis?What is the pathophysiology of IgE-mediated GI food allergies?What is the pathophysiology of pollen-food allergy syndrome (oral allergy syndrome)?What is the pathophysiology of mixed IgE/non-IgE GI food allergies?What are the upper and lower respiratory tract reactions to food allergies?What is the role of food allergies in the pathophysiology of asthma?What is the role of food allergies in the pathophysiology of food-induced pulmonary hemosiderosis (Heiner syndrome)?What is the role of IgE antibody-mediated responses in the pathogenesis of food allergies?What causes food allergies?What is the role of cell-mediated responses in the pathogenesis of food allergies?What are the physiologic characteristics of food allergens?What are risk factors for anaphylaxis from food allergies?What is the prevalence of food allergies?Which patient groups have the highest prevalence of food allergies?Which food allergies are most prevalent in children?What is the prognosis of food allergies?What is the risk for mortality from food allergies?What is included in patient education about food allergies?What are the signs and symptoms of food-induced anaphylaxis?What is included in the medical history for food allergies?What is the role of the physical exam findings in the evaluation of food allergies?Which conditions should be included in the differential diagnoses of food allergies?What are the differential diagnoses for Food Allergies?How are food allergies diagnosed?What is the role of serum studies in the workup of food allergies?What is the role of a diet diary in the workup of food allergies?What is the role of an elimination diet in the workup of food allergies?What is the role of skin testing in the workup of food allergies?What is the role of an oral food challenge in the diagnosis of food allergies?How is an open food challenge performed in the workup of food allergies?How is a single-blind food challenge performed in the workup of food allergies?How is a double-blind, placebo-controlled food challenge performed in the workup of food allergies?What is the role of intradermal skin testing in the workup of food allergies?What is the role of patch tests in the workup of food allergies?What is the role of peripheral serum measurements of eosinophils or total IgE concentrations in the diagnosis of food allergies?What is the role of basophil histamine-release assays in the diagnosis of food allergies?Which tests are not evidenced-based for the diagnosis of food allergies?How are food allergies treated?Which dietary modifications are used in the treatment of food allergies?What is the role of an emergency plan in the treatment of food allergies?What is the drug of choice for emergent treatment of food allergies?Which therapeutics are under investigation for the treatment of food allergies?Which specialist consultations are beneficial to patients with food allergies?How are food allergies prevented?Which medications are used in the treatment of food allergies?Which medications in the drug class Alpha/Beta Adrenergic Agonists are used in the treatment of Food Allergies?Which medications in the drug class Antihistamines are used in the treatment of Food Allergies?

Author

Scott H Sicherer, MD, Professor of Pediatrics, Jaffe Food Allergy Institute, Mount Sinai School of Medicine of New York University

Disclosure: Nothing to disclose.

Chief Editor

Michael A Kaliner, MD, Clinical Professor of Medicine, George Washington University School of Medicine; Medical Director, Institute for Asthma and Allergy

Disclosure: Nothing to disclose.

Acknowledgements

Dan Atkins, MD Assistant Professor, Department of Pediatrics, University of Colorado Health Sciences Center; Head, Division of Ambulatory Pediatrics, Department of Pediatrics, Director, Pediatric Day Program, National Jewish Medical and Research Center

Dan Atkins, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology and American Thoracic Society

Disclosure: Nothing to disclose.

Stephen C Dreskin, MD, PhD Professor of Medicine, Departments of Internal Medicine, Director of Allergy, Asthma, and Immunology Practice, University of Colorado Health Sciences Center

Stephen C Dreskin, MD, PhD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association for the Advancement of Science, American Association of Immunologists, American College of Allergy, Asthma and Immunology, Clinical Immunology Society, and Joint Council of Allergy, Asthma and Immunology

Disclosure: Genentech Consulting fee Consulting; American Health Insurance Plans Consulting fee Consulting; Johns Hopkins School of Public Health Consulting fee Consulting; Array BioPharma Consulting fee Consulting

John M James, MD Consulting Staff, Department of Pediatrics, Department of Allergy and Immunology, Colorado Allergy and Asthma Centers, PC

John M James, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Allergy Asthma and Immunology, American Academy of Pediatrics, American College of Allergy, Asthma and Immunology, American Medical Association, Colorado Medical Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References

  1. Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy. 2014 Dec. 69 (12):1582-7. [View Abstract]
  2. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol. 2001 Dec. 108(6):881-90. [View Abstract]
  3. Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013 Jan. 131(1):119-27.e1-7. [View Abstract]
  4. Jones SM, Burks AW, Dupont C. State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous. J Allergy Clin Immunol. 2014 Feb. 133 (2):318-23. [View Abstract]
  5. Sampson HA, Aceves S, Bock SA, James J, Jones S, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol. 2014 Nov. 134 (5):1016-25.e43. [View Abstract]
  6. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007 Apr. 119(4):1016-8. [View Abstract]
  7. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol. 1999 Sep. 104(3 Pt 2):S114-22. [View Abstract]
  8. Burks AW, James JM, Hiegel A, et al. Atopic dermatitis and food hypersensitivity reactions. J Pediatr. 1998 Jan. 132(1):132-6. [View Abstract]
  9. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics. 1998 Mar. 101(3):E8. [View Abstract]
  10. Sampson HA, McCaskill CC. Food hypersensitivity and atopic dermatitis: evaluation of 113 patients. J Pediatr. 1985 Nov. 107(5):669-75. [View Abstract]
  11. Sampson HA, Scanlon SM. Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr. 1989 Jul. 115(1):23-7. [View Abstract]
  12. Flinterman AE, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Acute allergic reactions in children with AEDS after prolonged cow's milk elimination diets. Allergy. 2006 Mar. 61 (3):370-4. [View Abstract]
  13. Hand L. Presence of Eczema May Affect Infant Food Allergies. Medscape Medical News. Available at http://www.medscape.com/viewarticle/808060. Accessed: July 22, 2013.
  14. Flohr C, Perkin M, Logan K, Marrs T, Radulovic S, Campbell LE, et al. Atopic Dermatitis and Disease Severity are the Main Risk Factors for Food Sensitization in Exclusively Breastfed Infants. J Invest Dermatol. 2013 Jul 18. [View Abstract]
  15. Webber CM, England RW. Oral allergy syndrome: a clinical, diagnostic, and therapeutic challenge. Ann Allergy Asthma Immunol. 2010 Feb. 104 (2):101-8; quiz 109-10, 117. [View Abstract]
  16. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007 Oct. 133(4):1342-63. [View Abstract]
  17. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011 Jul. 128(1):3-20.e6. [View Abstract]
  18. Powell GK. Food protein-induced enterocolitis of infancy: differential diagnosis and management. Compr Ther. 1986 Feb. 12(2):28-37. [View Abstract]
  19. Järvinen KM, Nowak-Węgrzyn A. Food protein-induced enterocolitis syndrome (FPIES): current management strategies and review of the literature. J Allergy Clin Immunol Pract. 2013 Jul-Aug. 1 (4):317-22. [View Abstract]
  20. Odze RD, Wershil BK, Leichtner AM, Antonioli DA. Allergic colitis in infants. J Pediatr. 1995 Feb. 126(2):163-70. [View Abstract]
  21. James JM. Respiratory manifestations of food allergy. Pediatrics. 2003 Jun. 111(6 Pt 3):1625-30. [View Abstract]
  22. Weber RW. Food additives and allergy. Ann Allergy. 1993 Mar. 70(3):183-90. [View Abstract]
  23. James JM, Eigenmann PA, Eggleston PA, Sampson HA. Airway reactivity changes in asthmatic patients undergoing blinded food challenges. Am J Respir Crit Care Med. 1996 Feb. 153(2):597-603. [View Abstract]
  24. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol. 2005 Jan. 115(1):3-12; quiz 13. [View Abstract]
  25. Vickery BP, Scurlock AM, Jones SM, Burks AW. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol. 2011 Mar. 127(3):576-84. [View Abstract]
  26. Lack G. Update on risk factors for food allergy. J Allergy Clin Immunol. 2012 May. 129 (5):1187-97. [View Abstract]
  27. Berin MC. Immunopathophysiology of food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2015 May. 135 (5):1108-13. [View Abstract]
  28. Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DY. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest. 1995 Feb. 95(2):913-8. [View Abstract]
  29. Commins SP, James HR, Stevens W, Pochan SL, Land MH, King C, et al. Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2014 Jul. 134 (1):108-15. [View Abstract]
  30. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001 Jan. 107(1):191-3. [View Abstract]
  31. Sloan AE, Powers ME. A perspective on popular perceptions of adverse reactions to foods. J Allergy Clin Immunol. 1986 Jul. 78(1 Pt 2):127-33. [View Abstract]
  32. Altman DR, Chiaramonte LT. Public perception of food allergy. J Allergy Clin Immunol. 1996 Jun. 97(6):1247-51. [View Abstract]
  33. Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007 Sep. 120(3):638-46. [View Abstract]
  34. Zuidmeer L, Goldhahn K, Rona RJ, Gislason D, Madsen C, Summers C, et al. The prevalence of plant food allergies: a systematic review. J Allergy Clin Immunol. 2008 May. 121(5):1210-1218.e4. [View Abstract]
  35. Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol. 2003 Dec. 112(6):1203-7. [View Abstract]
  36. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol. 2010 Feb. 125(2 Suppl 2):S116-25.
  37. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol. 2011 Mar. 127(3):594-602. [View Abstract]
  38. Gupta R, Warren C, Smith B, et al. Prevalence and Severity of Food Allergies Among US Adults. JAMA Netw Open. 2019 Jan 4. 2(1):
  39. Grundy J, Matthews S, Bateman B, Dean T, Arshad SH. Rising prevalence of allergy to peanut in children: Data from 2 sequential cohorts. J Allergy Clin Immunol. 2002 Nov. 110(5):784-9. [View Abstract]
  40. Kagan RS, Joseph L, Dufresne C, Gray-Donald K, Turnbull E, Pierre YS, et al. Prevalence of peanut allergy in primary-school children in Montreal, Canada. J Allergy Clin Immunol. 2003 Dec. 112(6):1223-8. [View Abstract]
  41. Hourihane JO, Aiken R, Briggs R, Gudgeon LA, Grimshaw KE, DunnGalvin A, et al. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J Allergy Clin Immunol. 2007 May. 119(5):1197-202. [View Abstract]
  42. Kristen D. Jackson, M.P.H.; LaJeana D. Howie, M.P.H., C.H.E.S.; Lara J. Akinbami, M.D. Trends in Allergic Conditions Among Children: United States, 1997-2011. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Available at http://www.cdc.gov/nchs/data/databriefs/db121.pdf. 2013 May;
  43. Wood RA. The natural history of food allergy. Pediatrics. 2003 Jun. 111(6 Pt 3):1631-7. [View Abstract]
  44. Skripak JM, Matsui EC, Mudd K, Wood RA. The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol. 2007 Nov. 120(5):1172-7. [View Abstract]
  45. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol. 2007 Dec. 120(6):1413-7. [View Abstract]
  46. Savage JH, Kaeding AJ, Matsui EC, Wood RA. The natural history of soy allergy. J Allergy Clin Immunol. 2010 Mar. 125(3):683-6. [View Abstract]
  47. Mehr S, Kakakios A, Frith K, Kemp AS. Food protein-induced enterocolitis syndrome: 16-year experience. Pediatrics. 2009 Mar. 123(3):e459-64. [View Abstract]
  48. Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007 Mar. 119(3):731-8. [View Abstract]
  49. Horan RF, Sheffer AL. Food-dependent exercise-induced anaphylaxis. Immunol Allergy Clin North Am. 1991. 757.
  50. Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS, et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol. 2009 Jun. 123 (6 Suppl):S365-83. [View Abstract]
  51. Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 2001 May. 107(5):891-6. [View Abstract]
  52. Maloney JM, Rudengren M, Ahlstedt S, Bock SA, Sampson HA. The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy. J Allergy Clin Immunol. 2008 Jul. 122(1):145-51. [View Abstract]
  53. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 1997 Oct. 100(4):444-51. [View Abstract]
  54. Wang J, Godbold JH, Sampson HA. Correlation of serum allergy (IgE) tests performed by different assay systems. J Allergy Clin Immunol. 2008 May. 121(5):1219-24. [View Abstract]
  55. Sicherer SH, Wood RA. Advances in diagnosing peanut allergy. J Allergy Clin Immunol Pract. 2013 Jan. 1 (1):1-13; quiz 14. [View Abstract]
  56. Klemans RJ, van Os-Medendorp H, Blankestijn M, Bruijnzeel-Koomen CA, Knol EF, Knulst AC. Diagnostic accuracy of specific IgE to components in diagnosing peanut allergy: a systematic review. Clin Exp Allergy. 2015 Apr. 45 (4):720-30. [View Abstract]
  57. Lin J, Bruni FM, Fu Z, Maloney J, Bardina L, Boner AL, et al. A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay. J Allergy Clin Immunol. 2012 May. 129 (5):1321-1328.e5. [View Abstract]
  58. Eigenmann PA, Sampson HA. Interpreting skin prick tests in the evaluation of food allergy in children. Pediatr Allergy Immunol. 1998 Nov. 9(4):186-91. [View Abstract]
  59. Bock SA, Lee WY, Remigio L, et al. Appraisal of skin tests with food extracts for diagnosis of food hypersensitivity. Clin Allergy. 1978 Nov. 8(6):559-64. [View Abstract]
  60. Knight AK, Shreffler WG, Sampson HA, Sicherer SH, Noone S, Mofidi S, et al. Skin prick test to egg white provides additional diagnostic utility to serum egg white-specific IgE antibody concentration in children. J Allergy Clin Immunol. 2006 Apr. 117(4):842-7. [View Abstract]
  61. Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol. 2005 Jun. 115(6):1291-6. [View Abstract]
  62. Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS. Work Group report: oral food challenge testing. J Allergy Clin Immunol. 2009 Jun. 123(6 Suppl):S365-83. [View Abstract]
  63. Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol. 1988 Dec. 82(6):986-97. [View Abstract]
  64. Spergel JM, Brown-Whitehorn T, Beausoleil JL, Shuker M, Liacouras CA. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol. 2007 Feb. 119(2):509-11. [View Abstract]
  65. Fogg MI, Brown-Whitehorn TA, Pawlowski NA, Spergel JM. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol. 2006 Aug. 17(5):351-5. [View Abstract]
  66. Mehl A, Rolinck-Werninghaus C, Staden U, Verstege A, Wahn U, Beyer K, et al. The atopy patch test in the diagnostic workup of suspected food-related symptoms in children. J Allergy Clin Immunol. 2006 Oct. 118(4):923-9. [View Abstract]
  67. Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol. 2010 Dec. 126(6):1105-18. [View Abstract]
  68. Sicherer SH, Mahr T. Management of Food Allergy in the School Setting. Pediatrics. 2010 Dec. 126(6):1232-1239. [View Abstract]
  69. Sicherer SH, Sampson HA. Food Allergy: Recent Advances in Pathophysiology and Treatment. Annu Rev Med. 2008 Aug 19. [View Abstract]
  70. Nowak-Wegrzyn A, Sampson HA. Future therapies for food allergies. J Allergy Clin Immunol. 2011 Mar. 127(3):558-73. [View Abstract]
  71. dbv technologies. DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients. February 26, 2018. Available at https://media.dbv-technologies.com/d286/ressources/_pdf/5/4511-PR-MILES-FINAL_ENG-PDF.pdf
  72. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015 Feb 26. 372 (9):803-13. [View Abstract]
  73. Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, et al. Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. N Engl J Med. 2016 Apr 14. 374 (15):1435-43. [View Abstract]
  74. Fleischer DM, Sicherer S, Greenhawt M, Campbell D, Chan E, et al. Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants. Pediatr Dermatol. 2016 Jan-Feb. 33 (1):103-6. [View Abstract]
  75. Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. N Engl J Med. 2016 May 5. 374 (18):1733-43. [View Abstract]
  76. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010 Sep. 126 (3):477-80.e1-42. [View Abstract]
  77. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015 Feb 26. 372 (9):803-13. [View Abstract]
  78. Hauk L. Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants: Consensus Communication. Am Fam Physician. 2016 Jan 1. 93 (1):61-2. [View Abstract]
  79. Lever R, MacDonald C, Waugh P, Aitchison T. Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol. 1998 Feb. 9(1):13-9. [View Abstract]
  80. Bock SA. Respiratory reactions induced by food challenges in children with pulmonary disease. Pediatr Allergy Immunol. 1992. 3:82.
  81. Roberts G, Patel N, Levi-Schaffer F, et al. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol. 2003 Jul. 112(1):168-74.
  82. Bock SA, Atkins FM. Patterns of food hypersensitivity during sixteen years of double-blind, placebo-controlled food challenges. J Pediatr. 1990 Oct. 117(4):561-7. [View Abstract]
  83. Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics. 1987 May. 79(5):683-8. [View Abstract]
  84. Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011 Jul. 128(1):e9-e17. [View Abstract]
  85. Pastorello EA, Stocchi L, Pravettoni V, et al. Role of the elimination diet in adults with food allergy. J Allergy Clin Immunol. 1989 Oct. 84(4 Pt 1):475-83. [View Abstract]
  86. Lemon-Mule H, Sampson HA, Sicherer SH, Shreffler WG, Noone S, Nowak-Wegrzyn A. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol. 2008 Nov. 122(5):977-983.e1. [View Abstract]
  87. Greer FR, Sicherer SH, Burks AW. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008 Jan. 121(1):183-91. [View Abstract]
  88. Allen KJ, Koplin JJ, Ponsonby AL, Gurrin LC, Wake M, Vuillermin P, et al. Vitamin D insufficiency is associated with challenge-proven food allergy in infants. J Allergy Clin Immunol. 2013 Apr. 131(4):1109-1116.e6. [View Abstract]
  89. James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med. 1995 May 11. 332(19):1262-6. [View Abstract]
  90. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011 Aug 26. 60(33):1128-32. [View Abstract]
  91. National Institute of Allergy and Infectious Diseases. Updated recommendations on influenza vaccine and people with egg allergy. Available at http://www.niaid.nih.gov/topics/vaccines/research/Pages/eggAllergy.aspx. Accessed: September 20, 2011.
  92. Varshney P, Jones SM, Scurlock AM, et al. A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011 Mar. 127(3):654-60. [View Abstract]
  93. Kim EH, Bird JA, Kulis M, Laubach S, Pons L, Shreffler W. Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2011 Mar. 127(3):640-646.e1. [View Abstract]
  94. Thyagarajan A, Varshney P, Jones SM, et al. Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol. 2010 Jul. 126(1):31-2. [View Abstract]
  95. Fisher HR, du Toit G, Lack G. Specific oral tolerance induction in food allergic children: is oral desensitisation more effective than allergen avoidance?: a meta-analysis of published RCTs. Arch Dis Child. 2011 Mar. 96(3):259-64. [View Abstract]
  96. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005 Mar. 115(3 Suppl 2):S483-523. [View Abstract]
  97. Begin P, Dominguez T, Wilson SP, et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol. 2014 Feb 20. 10(1):7. [View Abstract]
  98. Begin P, Winterroth LC, Dominguez T, et al. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol. 2014 Jan 15. 10(1):1. [View Abstract]
  99. Food-allergic kids need current Epi script. Medscape Medical News. November 18, 2013.
  100. Hackethal V. Omalizumab Aids Desensitization to Several Food Allergies. Medscape Medical News. Feb 28 2014.
  101. Johnson K. Antibiotic exposure in infancy linked to food allergies. Medscape Medical News. February 28, 2013. Available at http://www.medscape.com/viewarticle/780023. Accessed: March 4, 2013.